SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (667)8/16/2004 10:59:22 AM
From: nigel bates   of 1022
 
Where would CAT trade if it were getting its Humira royalties ?
:-(
(We might know in November.)
:-)

Problem with assessing ABGX is that egf accounts for too much of the current cap - might be a really interesting buy if it failed (not that I'm hoping for that).

Interesting how 162 emerged from under the radar at a fairly late stage (and it was a while after AMGN announced it that ABGX acknowledged it).
Could be a few more interesting mabs out there we don't know about ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News